Bioventus (BVS) Assets Average (2021 - 2026)

Bioventus (BVS) has reported Assets Average for 6 consecutive years, with $661.9 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Assets Average fell 5.32% year-over-year to $661.9 million; the trailing twelve-month figure through Jun 2026 stood at $661.9 million (down 5.32% YoY), and the FY2025 full-year result was $705.8 million, down 8.28% from the prior year.
• Assets Average retreated to $661.9 million in Q2 2026 per BVS's latest filing, from $667.0 million in the prior quarter.
• Across five years, Assets Average topped out at $1.4 billion in Q4 2022 and bottomed at $661.9 million in Q2 2026.
• Historically, Assets Average has averaged $888.4 million across 5 years, with a median of $797.9 million in 2024.
• The sharpest annual moves came in 2022 and 2023: Assets Average soared 113.0% in 2022, then slumped 41.46% in 2023.
• Over 5 years, Assets Average stood at $1.4 billion in 2022, then tumbled by 41.46% to $811.0 million in 2023, then decreased by 7.68% to $748.7 million in 2024, then slipped by 7.5% to $692.6 million in 2025, then fell by 4.42% to $661.9 million in 2026.
• According to Business Quant data, Assets Average over the past three periods registered $661.9 million, $667.0 million, and $692.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.